Medical News

Baseline Basophil Count Predicts Recurrence in High Grade T1 Bladder Cancer Patients Treated with Intravesical BCG

Baseline basophil count could be useful in predicting the recurrence in high-grade T1 bladder cancer patients who received intravesical Bacillus...

25 Apr, 2019

Email this page
Adjuvant Radiotherapy Improves Outcomes in Advanced, Non-Metastatic Upper Tract Urothelial Carcinoma

Adjuvant radiation therapy reduced the recurrence, distant metastasis and mortality in patients with peripelvic/ periureteral fat-infiltrating (pT3b...

05 Apr, 2019

Email this page
Preoperative Predictors of The Return to Immediate Urinary Continence Post RS-RARP

A recent study reported return to immediate urinary continence in 77.27% of the patients who underwent Retzius-sparing robot-assisted radical...

04 Apr, 2019

Email this page
ADT Increases the Risk of Other Cause Mortality in Elderly Patients with Localized Prostate Cancer

A recent retrospective study concluded that androgen deprivation therapy (ADT) for ≥2 years significantly increases the risk of mortality due to...

20 Mar, 2019

Email this page

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Erlotinib Update

This publication presents various studies on the anticancer drug, erlotinib.

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

Email this page

Key Trials

LANDSCAPE TRIAL: Lapatinib in Combination with Capecitabine Active As First-line Treatment of Brain Metastases from HER2-positive Breast Cancer

This is the first prospective phase 2 trial assessing a combination of chemotherapy and targeted therapy in patients with previously untreated brain...

Risk Predictors of Brain Metastases Development in Patients with HER2- Positive Breast Cancer

This study presents the risk factors for the development of the brain metastases for early and advanced (metastatic) HER2+breast cancer, local...

GeparQuinto Trial: Lapatinib versus Trastuzumab in Combination with Chemotherapy for Treatment of HER2-positive Primary Breast Cancer

GeparQuinto trial is phase 3 study comparing lapatinib versus trastuzumab in combination with chemotherapy for treatment of HER2-positive primary...

SWISH Trial: Dexamethasone Oral Solution Four Times a Day, Keeps Stomatitis Away

The SWISH trial investigated the prophylactic use of dexamethasone-based mouthwash for stomatitis in women receiving everolimus and exemestane for...

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

Myths and Facts about Cancer

Throughout the years there have been many cancer myths floating around. This article will help clear the myths related to cancer.


Explore >>

Currently there is no content under this category.


Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
43% (3 votes)
Tegafur uracil
0% (0 votes)
57% (4 votes)
Total votes: 7